WOLVERINE TRADING, LLC - HALOZYME THERAPEUTICS INC ownership

HALOZYME THERAPEUTICS INC's ticker is HALO and the CUSIP is 40637H109. A total of 386 filers reported holding HALOZYME THERAPEUTICS INC in Q3 2023. The put-call ratio across all filers is 0.45 and the average weighting 0.1%.

Quarter-by-quarter ownership
WOLVERINE TRADING, LLC ownership history of HALOZYME THERAPEUTICS INC
ValueSharesWeighting
Q3 2023$1,275,536
+152658.8%
33,391
+49.1%
0.00%0.0%
Q1 2023$835
-99.8%
22,400
+202.7%
0.00%0.0%
Q2 2022$335,000
+20.5%
7,400
+7.2%
0.00%
Q1 2022$278,000
-60.8%
6,900
-60.8%
0.00%
Q4 2021$710,0000.0%17,600
-1.7%
0.00%
-100.0%
Q3 2021$710,000
+22.2%
17,900
+40.9%
0.00%
Q2 2021$581,000
+183.4%
12,700
+154.1%
0.00%
Q1 2021$205,000
-50.8%
4,999
-49.0%
0.00%
-100.0%
Q4 2020$417,000
-42.6%
9,800
-64.2%
0.00%
-50.0%
Q3 2020$726,000
-24.1%
27,400
-26.1%
0.00%
-33.3%
Q2 2020$957,000
+63.6%
37,056
+15.1%
0.00%
+50.0%
Q1 2020$585,000
-36.1%
32,200
-37.2%
0.00%
-33.3%
Q4 2019$915,000
+42.3%
51,300
+21.3%
0.00%
+200.0%
Q3 2019$643,000
+9.9%
42,300
+24.1%
0.00%0.0%
Q2 2019$585,000
-16.2%
34,093
-21.3%
0.00%
-66.7%
Q1 2019$698,000
-49.2%
43,334
-54.9%
0.00%
-25.0%
Q4 2018$1,373,000
-15.5%
96,089
+7.4%
0.00%
+33.3%
Q3 2018$1,625,000
-52.8%
89,455
-49.1%
0.00%
-62.5%
Q2 2018$3,444,0000.0%175,8030.0%0.01%0.0%
Q1 2018$3,444,000
-35.7%
175,803
-33.5%
0.01%
-60.0%
Q4 2017$5,359,000
+71.9%
264,541
+47.4%
0.02%
+66.7%
Q3 2017$3,118,000
+25.8%
179,508
-6.0%
0.01%
+9.1%
Q2 2017$2,479,000
-15.5%
191,011
-15.2%
0.01%
-31.2%
Q1 2017$2,934,000
+124.7%
225,122
+45.2%
0.02%
+100.0%
Q2 2016$1,306,000155,0000.01%
Other shareholders
HALOZYME THERAPEUTICS INC shareholders Q3 2023
NameSharesValueWeighting ↓
Third Security, LLC 1,129,551$47,091,0006.38%
First Light Asset Management, LLC 2,011,350$83,853,0005.56%
TRAN CAPITAL MANAGEMENT, L.P. 1,353,208$56,415,0005.03%
SNYDER CAPITAL MANAGEMENT L P 2,920,860$121,771,0003.50%
DOHENY ASSET MANAGEMENT /CA 120,028$5,004,0003.39%
SILVERARC CAPITAL MANAGEMENT, LLC 104,945$4,375,0002.39%
Redwood Investments, LLC 542,764$22,628,0001.99%
Kent Lake Capital LLC 85,000$3,544,0001.44%
Lisanti Capital Growth, LLC 263,460$10,984,0001.41%
Bellevue Group AG 3,011,966$125,569,0001.33%
View complete list of HALOZYME THERAPEUTICS INC shareholders